August 2022         
Today's Date: October 6, 2022
SDAIA, Google Cloud to launch training program to empower women in AI sector   •   Test Release special characters in the headline © ® ™ é ñ ü ç î ò   •   Test Release special characters in the headline © ® ™ é ñ ü ç î ò   •   Greenwood and Travis Hunter Sign NIL Deal and Partner to Launch the “Choose Black” Campaign   •   “What I Want to Know with Kevin P. Chavous” Podcast Launches Third Season in Search of Answers to Education’s   •   FEID SELLS OUT 2022 "U.S. TRIP" SHOW DATES IN JUST MINUTES   •   LIBERTY Dental Plan of New York Awards 12 Scholarships in Partnership with PENCIL   •   U.S. Institute of Peace Announces Finalists For 2022 Women Building Peace Award   •   Mogul Launches Nationwide Campaign Called “Build Better Boards” to Champion More Diverse Boards   •   BFF LAUNCHES FIRST COMMUNITY NATIONWIDE MEET UP SERIES, "BRING YOUR BFF TO WEB3"   •   A female-led waste management platform from California has raised $8M to scale an innovative approach to the refuse problems of   •   LIBERTY Dental Plan of New York Awards 12 Scholarships in Partnership with PENCIL   •   Novel Clinical Trial Begins to Help Black and Latina Women Concerned About Chemotherapy-Induced Hair Loss   •   United Through Reading Appoints Tim Farrell as Chief Executive Officer   •   Greenwood and Travis Hunter Sign NIL Deal and Partner to Launch the “Choose Black” Campaign   •   El Kiddo: Meet the two female Kazakhstan entrepreneurs who want your children to love the mountains   •   Poll: Over Half of Voters of Color Oppose Government Negotiation of Drug Prices Once They Learn About Consequences for Patients   •   Mogul Launches Nationwide Campaign Called “Build Better Boards” to Champion More Diverse Boards   •   Japan Patent Office Publishes Green Transformation Technologies Inventory (GXTI), Helping Enterprises and Others Objectively Exp   •   With So Many Opportunities Available, Children Can Choose Among Many Paths To Serve God

Notice: Undefined index: currentSection in /home/blackradionetwork/public_html/page.php on line 176
Bookmark and Share

New Medicines, New Hope for African Americans


 

WASHINGTON,  -- A recent article in The Triangle Tribune pointed to good news for members of the black community, highlighting new medicines in development to fight diseases of particular concern to African Americans.

America's pharmaceutical research and biotechnology companies are developing new medicines to help fight asthma, diabetes, sickle cell anemia and cancer.

African Americans have higher asthma rates than any other racial and ethnic group in the United States, and are three times more likely to die from asthma, according to the American Lung Association. One new medicine now being developed represents a new generation of inhaled corticosteroids. The medicine is intended to reduce inflammation in the lungs and airways.

Similarly, African Americans are nearly two times more likely to have diabetes than whites, according to the American Diabetes Association. A recent survey by the Pharmaceutical Research and Manufacturers of America (PhRMA) reveals that one medicine now in development has been shown to improve both long-term glycemic control, and the imbalance between insulin and glucose that causes type 2 diabetes.

Black women are 10 percent less likely to be diagnosed with breast cancer but are 35 percent more likely to die from the disease, according to the U.S. Department of Health and Human Services' Office of Minority Health. A new medicine in the pipeline for breast cancer targets the Bcl-2 protein. By reducing the amount of this protein in cancer cells, the medicine may enhance the effectiveness of chemotherapy.

Black men are nearly 2.5 times as likely to die from prostate cancer as white men, according to the Office of Minority Health. Several vaccines are currently being studied as possible treatments for cancer. One potential vaccine has tripled the survival rate of men with advanced prostate cancer in clinical trials.

An inherited disorder, sickle cell anemia can clog the blood vessels, depriving the patient of oxygen and often causing severe pain, progressive organ failure and reduced life span. One medicine now in development is designed to address a problem with the lining of the blood vessels. Studies suggest that this dysfunction may play a role in sickle cell and the vascular problems associated with it.

These are just a sampling of the diseases that disproportionately affect African Americans that are currently being targeted for new drug development.

 

SOURCE Pharmaceutical Research and Manufacturers of America



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News